# Gastroenterology (inflammatory bowel disease) Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Lili Boulanger (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET025-SYN-TD
- Date: 1915-01-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Odile Marchetti-Rowe, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Thaddeus Nwankwo-Delacroix, MD, Gastroenterology (inflammatory bowel disease)
- Urgency: Urgent, within two weeks

## Referral question

Suspected inflammatory bowel disease in a woman of 21 with four months of right lower abdominal pain, diarrhea, fevers, and weight loss, with iron deficiency anemia and a fecal calprotectin of 1240 ug/g. Ileocolonoscopy, MR enterography, and tuberculosis screening are being arranged. Please see her once they are done to confirm the diagnosis and plan treatment with her. **S**

## Questions for the consultant

1. Do the endoscopic, histologic, and imaging findings confirm Crohn disease, and is intestinal tuberculosis adequately excluded?
2. How would you classify her disease and its risk of a disabling course?
3. Which advanced therapy do you recommend, and should a corticosteroid bridge be used?
4. What screening and vaccines are needed before immunosuppression?
5. How should her anemia, nutrition, and bone health be managed?
6. What are the treatment targets and the monitoring plan, and what should she know about fertility and pregnancy?

## Pertinent history

Crampy right lower quadrant pain, loose stools up to six times a day including at night, evening temperatures to 37.6 °C, and loss of 6 kg over four months; frail health and a serious pneumonia in early childhood. On examination BMI 17.6, mild right lower quadrant tenderness, and a normal perianal examination. Hemoglobin 10.6 g/dL, MCV 76, ferritin 9, platelets 452, CRP 38 mg/L, albumin 3.3 g/dL, vitamin D 18 ng/mL, B12 normal. Never smoker; no regular medicines except acetaminophen; no known allergy. Not sexually active. She is a composer with a concert of her choral works in late March. Tuberculosis is an important alternative diagnosis, so no steroid has been started. **S**

- Lili Boulanger was born Marie-Juliette Olga Boulanger on August 21, 1893, in the 9th arrondissement of Paris. **D**
- She was a composer, the sister of the composer and teacher Nadia Boulanger (1887–1979). **D**
- At about two years old, in 1895, she had pneumonia, described as bronchial pneumonia; her health was frail from a very young age and she remained sickly for the rest of her life. **D**
- The usual account is that the childhood pneumonia left her immune system weakened, so that she never fully recovered. **R**
- In 1913, at 19, she became the first woman to win the Premier Grand Prix de Rome for musical composition, with the cantata Faust et Hélène; she had been the only woman among the five finalists that May. **D**
- She went to the Villa Medici in Rome in 1914. The outbreak of war made her leave Rome for Nice, where she composed the song cycle Clairières dans le ciel; she stayed in Rome again in 1916 and then returned to France. **D**
- Early in 1915, living in Paris, she began to have headaches, loss of appetite, and fever, followed by symptoms resembling colitis and appendicitis; she spent much of her time in bed but kept composing. **D**

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: PHQ-2: 2; Hemoglobin: 10.6 g/dL (low); MCV: 76 fL (low); White cell count: 9.8 10*3/uL; Platelets: 452 10*3/uL (high); CRP: 38 mg/L (high); Fecal calprotectin: 1240 ug/g (high); Albumin: 3.3 g/dL (low); Ferritin: 9 ng/mL (low); Vitamin B12: 310 pg/mL; 25-hydroxyvitamin D: 18 ng/mL (low); ALT: 16 U/L; AST: 19 U/L; Creatinine: 0.7 mg/dL. All results are synthetic.

BP 104/66 mmHg; pulse 96 bpm; respirations 16/min; temperature 37.6 °C; oxygen saturation 99% on room air; weight 45 kg; BMI 17.6 kg/m². All vital signs are synthetic.

## Current medications

- Acetaminophen 500 mg oral tablet, one or two tablets by mouth up to every 6 hours as needed for abdominal pain, no more than 3000 mg a day; no nonsteroidal anti-inflammatory drugs **S**

## Plan so far

- Workup for suspected inflammatory bowel disease: blood count, CRP, albumin, iron studies, vitamin B12 and D, fecal calprotectin, stool tests for Clostridioides difficile and enteric pathogens, celiac serology, a pregnancy test, ileocolonoscopy with biopsies, and MR enterography. Guideline: ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol 2025;120(6):1225-1264 (2025); ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019 (2019) **S**
- Exclude intestinal tuberculosis before any steroid or immunosuppressive drug: interferon-gamma release assay, chest X-ray, and ileal and colonic biopsies for acid-fast stain, TB PCR, and mycobacterial culture; with hepatitis B, hepatitis C, HIV, measles, and varicella serology before treatment. Guideline: ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol 2025;120(6):1225-1264 (2025); ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis 2026 (2026) **S**
- Nutrition: dietitian assessment, small frequent meals with oral nutritional supplements, and weight at every visit. Guideline: ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. J Crohns Colitis 2024;18(10):1531-1555 (2024); ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol 2025;120:1447-1473 (2025) **S**
- Mood, anxiety, and work: PHQ-9 and GAD-7 at intervals, IBD psychology if needed, and a practical plan for composing and performing during treatment. Guideline: ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol 2025;120:1447-1473 (2025) **S**
